Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Rheumatol

Retrieve available abstracts of 222 articles:
HTML format
Text format



Single Articles


    September 2017
  1. PIERINGER H, Hintenberger R, Pohanka E, Steinwender C, et al
    RABBIT risk score and ICU admission due to infection in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Sep 14. doi: 10.1007/s10067-017-3825.
    PubMed     Text format     Abstract available


  2. SAKTHISWARY R, Rajalingam S, Hussein H, Sridharan R, et al
    Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
    Clin Rheumatol. 2017 Sep 9. doi: 10.1007/s10067-017-3817.
    PubMed     Text format     Abstract available


  3. REN J, Sun L, Zhao J
    Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis.
    Clin Rheumatol. 2017 Sep 8. doi: 10.1007/s10067-017-3809.
    PubMed     Text format     Abstract available


  4. MORI S, Yoshitama T, Hirakata N, Ueki Y, et al
    Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals.
    Clin Rheumatol. 2017 Sep 7. doi: 10.1007/s10067-017-3804.
    PubMed     Text format     Abstract available


  5. AHLUWALIA V, Rampakakis E, Movahedi M, Cesta A, et al
    Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative.
    Clin Rheumatol. 2017 Sep 6. doi: 10.1007/s10067-017-3805.
    PubMed     Text format     Abstract available


  6. GONG X, Xu SQ, Wu Y, Ma CC, et al
    Elevated serum 14-3-3eta protein may be helpful for diagnosis of early rheumatoid arthritis associated with secondary osteoporosis in Chinese population.
    Clin Rheumatol. 2017 Sep 5. doi: 10.1007/s10067-017-3807.
    PubMed     Text format     Abstract available


  7. ZHANG F, Ma C
    Comparison of the effectiveness on intra-articular and subcutaneous TNF inhibitor in rheumatoid arthritis patients.
    Clin Rheumatol. 2017 Sep 4. doi: 10.1007/s10067-017-3806.
    PubMed     Text format     Abstract available


    August 2017
  8. HAMMAM N, Gheita TA
    Impact of secondhand smoking on disease activity in women with rheumatoid arthritis.
    Clin Rheumatol. 2017 Aug 25. doi: 10.1007/s10067-017-3795.
    PubMed     Text format     Abstract available


  9. SANTOS-MORENO P, Caballero-Uribe CV, Massardo ML, Maldonado CG, et al
    Systematic and progressive implementation of the centers of excellence for rheumatoid arthritis: a methodological proposal.
    Clin Rheumatol. 2017 Aug 24. doi: 10.1007/s10067-017-3790.
    PubMed     Text format     Abstract available


  10. SUN X, Deng X, Geng Y, Ji L, et al
    A simplified and validated ultrasound scoring system to evaluate synovitis of bilateral wrists and hands in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Aug 22. doi: 10.1007/s10067-017-3785.
    PubMed     Text format     Abstract available


  11. JEAN S, Hudson M, Gamache P, Bessette L, et al
    Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study.
    Clin Rheumatol. 2017 Aug 21. doi: 10.1007/s10067-017-3796.
    PubMed     Text format     Abstract available


  12. HATTORI Y, Kida D, Kaneko A
    Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity.
    Clin Rheumatol. 2017 Aug 19. doi: 10.1007/s10067-017-3791.
    PubMed     Text format     Abstract available


  13. D'AGOSTINO MA, Alten R, Mysler E, Le Bars M, et al
    Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Aug 18. doi: 10.1007/s10067-017-3788.
    PubMed     Text format     Abstract available


  14. WANG B, Tang Y, Sun X, Ouyang X, et al
    Increased IL-6 expression on THP-1 by IL-34 stimulation up-regulated rheumatoid arthritis Th17 cells.
    Clin Rheumatol. 2017 Aug 15. doi: 10.1007/s10067-017-3746.
    PubMed     Text format     Abstract available


  15. MUELLER RB, Graninger W, Sidiropoulos P, Goger C, et al
    Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysi
    Clin Rheumatol. 2017 Aug 3. doi: 10.1007/s10067-017-3779.
    PubMed     Text format     Abstract available


    July 2017
  16. GAUBITZ M, Gottl KH, Behmer O, Lippe R, et al
    Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study.
    Clin Rheumatol. 2017 Jul 30. doi: 10.1007/s10067-017-3757.
    PubMed     Text format     Abstract available


  17. JAHID M, Rehan-Ul-Haq, Jha PK, Chawla D, et al
    Tumor necrosis factor-alpha -308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-alpha.
    Clin Rheumatol. 2017 Jul 27. doi: 10.1007/s10067-017-3774.
    PubMed     Text format     Abstract available


  18. FENG ZT, Xu J, He GC, Cai SJ, et al
    A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.
    Clin Rheumatol. 2017 Jul 27. doi: 10.1007/s10067-017-3770.
    PubMed     Text format     Abstract available


  19. PALAMAR D, Er G, Terlemez R, Ustun I, et al
    Disease activity, handgrip strengths, and hand dexterity in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Jul 18. doi: 10.1007/s10067-017-3756.
    PubMed     Text format     Abstract available


  20. HARROLD LR, John A, Best J, Zlotnick S, et al
    Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry.
    Clin Rheumatol. 2017 Jul 17. doi: 10.1007/s10067-017-3742.
    PubMed     Text format     Abstract available


  21. WANG P, Li S, Liu LN, Lv TT, et al
    Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.
    Clin Rheumatol. 2017 Jul 11. doi: 10.1007/s10067-017-3747.
    PubMed     Text format     Abstract available


  22. BOLETO G, Drame M, Lambrecht I, Eschard JP, et al
    Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature.
    Clin Rheumatol. 2017 Jul 1. doi: 10.1007/s10067-017-3722.
    PubMed     Text format     Abstract available


    June 2017
  23. HANNAWI S, AlSalmi I, Moller I, Naredo E, et al
    Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.
    Clin Rheumatol. 2017 Jun 30. doi: 10.1007/s10067-017-3737.
    PubMed     Text format     Abstract available


  24. BAPTISTA TSA, Petersen LE, Molina JK, de Nardi T, et al
    Autoantibodies against myelin sheath and S100beta are associated with cognitive dysfunction in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Jun 27. doi: 10.1007/s10067-017-3724.
    PubMed     Text format     Abstract available


  25. BACALAO EJ, Greene GJ, Beaumont JL, Eisenstein A, et al
    Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.
    Clin Rheumatol. 2017 Jun 26. doi: 10.1007/s10067-017-3731.
    PubMed     Text format     Abstract available


  26. HAN J, Geng Y, Deng X, Zhang Z, et al
    Risk factors of flare in rheumatoid arthritis patients with both clinical and ultrasonographic remission: a retrospective study from China.
    Clin Rheumatol. 2017 Jun 22. doi: 10.1007/s10067-017-3736.
    PubMed     Text format     Abstract available


  27. SYNGLE A, Kaur S, Verma I, Syngle T, et al
    Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Clin Rheumatol. 2017 Jun 21. doi: 10.1007/s10067-017-3725.
    PubMed     Text format     Abstract available


  28. FASSIO A, Idolazzi L, Viapiana O, Benini C, et al
    In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls.
    Clin Rheumatol. 2017 Jun 20. doi: 10.1007/s10067-017-3734.
    PubMed     Text format     Abstract available


  29. XIE X, Li F, Li S, Tian J, et al
    Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis.
    Clin Rheumatol. 2017 Jun 10. doi: 10.1007/s10067-017-3639.
    PubMed     Text format     Abstract available


  30. ROJAS-SERRANO J, Herrera-Bringas D, Perez-Roman DI, Perez-Dorame R, et al
    Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Clin Rheumatol. 2017 Jun 6. doi: 10.1007/s10067-017-3707.
    PubMed     Text format     Abstract available


  31. SAG S, Sag MS, Tekeoglu I, Kamanli A, et al
    Nailfold videocapillaroscopy results in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Jun 4. doi: 10.1007/s10067-017-3696.
    PubMed     Text format     Abstract available


  32. VOS I, Van Mol C, Trouw LA, Mahler M, et al
    Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
    Clin Rheumatol. 2017 Jun 3. doi: 10.1007/s10067-017-3684.
    PubMed     Text format     Abstract available


  33. STOJANOVIC S, Bojana Stamenkovic, Stoimenov TJ, Nedovic J, et al
    Association of tumor necrosis factor-alpha (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
    Clin Rheumatol. 2017 Jun 1. doi: 10.1007/s10067-017-3699.
    PubMed     Text format     Abstract available


    May 2017
  34. ROBUSTILLO-VILLARINO M, Alegre-Sancho JJ, Rodilla-Sala E, Corrales A, et al
    Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 May 25. doi: 10.1007/s10067-017-3680.
    PubMed     Text format     Abstract available


  35. JAUREGUI JJ, Paul Hovis J, Ashfaq Hasan S
    Characteristics of rheumatoid arthritis patients undergoing reverse shoulder arthroplasty.
    Clin Rheumatol. 2017 May 24. doi: 10.1007/s10067-017-3679.
    PubMed     Text format     Abstract available


  36. EISSA M, El Shafey A, Hammad M
    Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study.
    Clin Rheumatol. 2017 May 22. doi: 10.1007/s10067-017-3674.
    PubMed     Text format     Abstract available


  37. WANG X, Ma C, Li P, Zhao F, et al
    Effects of iguratimod on the levels of circulating regulators of bone remodeling and bone remodeling markers in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 May 4. doi: 10.1007/s10067-017-3668.
    PubMed     Text format     Abstract available


    April 2017
  38. RAHNE T, Clauss F, Plontke SK, Keysser G, et al
    Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener's granulomatosis), or systemic lupus erythematosus.
    Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3651.
    PubMed     Text format     Abstract available


  39. SHIMIZU Y, Nakajima A, Inoue E, Shidara K, et al
    Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
    Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3634.
    PubMed     Text format     Abstract available


  40. ANYFANTI P, Triantafyllou A, Gkaliagkousi E, Triantafyllou G, et al
    Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors.
    Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3659.
    PubMed     Text format     Abstract available


  41. DONISAN T, Bojinca VC, Dobrin MA, Balanescu DV, et al
    The relationship between disease activity, quality of life, and personality types in rheumatoid arthritis and ankylosing spondylitis patients.
    Clin Rheumatol. 2017 Apr 27. doi: 10.1007/s10067-017-3654.
    PubMed     Text format     Abstract available


  42. SON KM, Lee SY, Seo YI, Choi JE, et al
    Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.
    Clin Rheumatol. 2017 Apr 27. doi: 10.1007/s10067-017-3628.
    PubMed     Text format     Abstract available


  43. EL-LEBEDY D, Raslan H, Ibrahim A, Ashmawy I, et al
    Association of STAT4 rs7574865 and PTPN22 rs2476601 polymorphisms with rheumatoid arthritis and non-systemically reacting antibodies in Egyptian patients.
    Clin Rheumatol. 2017 Apr 19. doi: 10.1007/s10067-017-3632.
    PubMed     Text format     Abstract available


  44. TAKEUCHI H, Kawasaki T, Shigematsu K, Kawamura K, et al
    Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis.
    Clin Rheumatol. 2017;36:913-917.
    PubMed     Text format     Abstract available


    March 2017
  45. CUOMO G, D'Abrosca V, Iacono D, Pantano I, et al
    Erratum to: The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Mar 28. doi: 10.1007/s10067-017-3614.
    PubMed     Text format    


  46. MURALIDHARAN N, Misra DP, Jain VK, Negi VS, et al
    Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Mar 27. doi: 10.1007/s10067-017-3608.
    PubMed     Text format     Abstract available


  47. RAMIREZ-PEREZ S, Salazar-Paramo M, Pineda-Monjaras S, De la Cruz-Mosso U, et al
    Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis.
    Clin Rheumatol. 2017 Mar 25. doi: 10.1007/s10067-017-3610.
    PubMed     Text format     Abstract available


  48. LI C, Wang XR, Ji HJ, Zhang XY, et al
    Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
    Clin Rheumatol. 2017 Mar 24. doi: 10.1007/s10067-017-3596.
    PubMed     Text format     Abstract available


    February 2017
  49. PARK DJ, Choi SJ, Shin K, Kim HA, et al
    Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.
    Clin Rheumatol. 2017 Feb 27. doi: 10.1007/s10067-017-3584.
    PubMed     Text format     Abstract available


  50. ZHANG Y, Li H, Wu N, Dong X, et al
    Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2017 Feb 12. doi: 10.1007/s10067-017-3561.
    PubMed     Text format     Abstract available


  51. BOMAN A, Kokkonen H, Arlestig L, Berglin E, et al
    Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis.
    Clin Rheumatol. 2017 Feb 11. doi: 10.1007/s10067-017-3570.
    PubMed     Text format     Abstract available


  52. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.
    Clin Rheumatol. 2017 Feb 1. doi: 10.1007/s10067-017-3551.
    PubMed     Text format     Abstract available


  53. XIAO F
    Neuromyotonia as an unusual neurological complication of primary Sjogren's syndrome: case report and literature review.
    Clin Rheumatol. 2017;36:481-484.
    PubMed     Text format     Abstract available


  54. CIPRIANI P, Berardicurti O, Masedu F, D'Onofrio F, et al
    Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study.
    Clin Rheumatol. 2017;36:251-260.
    PubMed     Text format     Abstract available


  55. AKDEMIR G, Markusse IM, Goekoop-Ruiterman YP, Steup-Beekman GM, et al
    Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.
    Clin Rheumatol. 2017;36:317-326.
    PubMed     Text format     Abstract available


    January 2017
  56. LIU JH, Ng MY, Cheung T, Chung HY, et al
    Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Jan 26. doi: 10.1007/s10067-016-3536.
    PubMed     Text format     Abstract available


  57. ISOGAI T, Matsui H, Tanaka H, Yokogawa N, et al
    Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan.
    Clin Rheumatol. 2017 Jan 26. doi: 10.1007/s10067-017-3555.
    PubMed     Text format     Abstract available


  58. ANDREWS JS, Trupin L, Yelin EH, Hough CL, et al
    Frailty and reduced physical function go hand in hand in adults with rheumatoid arthritis: a US observational cohort study.
    Clin Rheumatol. 2017 Jan 23. doi: 10.1007/s10067-017-3541.
    PubMed     Text format     Abstract available


  59. ALPIZAR-RODRIGUEZ D, Brulhart L, Mueller RB, Moller B, et al
    The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.
    Clin Rheumatol. 2017 Jan 21. doi: 10.1007/s10067-017-3547.
    PubMed     Text format     Abstract available


  60. MONTI S, Klersy C, Gorla R, Sarzi-Puttini P, et al
    Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.
    Clin Rheumatol. 2017 Jan 5. doi: 10.1007/s10067-016-3528.
    PubMed     Text format     Abstract available


  61. LIU C, Zhang H, Yao G, Hu Y, et al
    Characteristics of primary Sjogren's syndrome patients with IgG4 positive plasma cells infiltration in the labial salivary glands.
    Clin Rheumatol. 2017;36:83-88.
    PubMed     Text format     Abstract available


  62. MUELLER RB, Reshiti N, Kaegi T, Finckh A, et al
    Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
    Clin Rheumatol. 2017;36:59-66.
    PubMed     Text format     Abstract available


  63. ITO T, Tamura N, Okuda S, Tada K, et al
    Elevated serum levels of soluble CD146 in patients with systemic sclerosis.
    Clin Rheumatol. 2017;36:119-124.
    PubMed     Text format     Abstract available


    December 2016
  64. CHEUNG PP, Lahiri M, March L, Gossec L, et al
    Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis.
    Clin Rheumatol. 2016 Dec 30. doi: 10.1007/s10067-016-3522.
    PubMed     Text format     Abstract available


  65. UNRIZA-PUIN S, Bautista-Molano W, Lafaurie GI, Valle-Onate R, et al
    Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives?
    Clin Rheumatol. 2016 Dec 28. doi: 10.1007/s10067-016-3519.
    PubMed     Text format     Abstract available


  66. MUNOZ JG, Giraldo RB, Santos AM, Bello-Gualteros JM, et al
    Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis.
    Clin Rheumatol. 2016 Dec 24. doi: 10.1007/s10067-016-3521.
    PubMed     Text format     Abstract available


  67. BISI MC, do Prado AD, Piovesan DM, Bredemeier M, et al
    Ultrasound resistive index, power Doppler, and clinical parameters in established rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available



  68. Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  69. SCANLON EM, Mankad R, Crowson CS, Kullo IJ, et al
    Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  70. LUTEREK-PUSZYNSKA K, Malinowski D, Paradowska-Gorycka A, Safranow K, et al
    CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  71. IANNONE F, Courvoisier DS, Gottenberg JE, Hernandez MV, et al
    Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  72. BAROUTA G, Katsiari CG, Alexiou I, Liaskos C, et al
    Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  73. WAKABAYASHI H, Inada H, Nishioka Y, Hasegawa M, et al
    Maintenance of efficacy and safety with subcutaneous golimumab in rheumatoid arthritis patients with low disease activity who previously received TNF inhibitors.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  74. ORNBJERG LM, Ostergaard M, Jensen T, Horslev-Petersen K, et al
    Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  75. KIHARA M, Davies R, Kearsley-Fleet L, Watson KD, et al
    Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  76. KABEERDOSS J, Sandhya P, Mandal SK, Gowri M, et al
    High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2016;35:3063-3067.
    PubMed     Text format     Abstract available


    November 2016
  77. LENERT A, Lenert P
    Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  78. BASIC Z, Jerkovic I, Kruzic I, Andelinovic S, et al
    Rich but poor: life in the Roman period with extreme rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  79. HOPKINS AM, Wiese MD, O'Doherty CE, Proudman SM, et al
    Putting recommendations into practice: Australian rheumatologists' opinions on leflunomide use in rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  80. SHIMADA K, Komiya A, Yokogawa N, Nishino J, et al
    Impact of the size and number of swollen joints on serum C-reactive protein level and erythrocyte sedimentation rate in rheumatoid arthritis: a cross-sectional study in Japan.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  81. NAKAJIMA A, Aoki Y, Sonobe M, Takahashi H, et al
    Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  82. JI L, Deng X, Geng Y, Song Z, et al
    The additional benefit of ultrasonography to 2010 ACR/EULAR classification criteria when diagnosing rheumatoid arthritis in the absence of anti-cyclic citrullinated peptide antibodies.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  83. CHEN HH, Chen DY, Chen YM, Lai KL, et al
    Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  84. MERDLER-RABINOWICZ R, Tiosano S, Comaneshter D, Cohen AD, et al
    Comorbidity of gout and rheumatoid arthritis in a large population database.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  85. HUSBERG M, Davidson T, Hallert E
    Non-medical costs during the first year after diagnosis in two cohorts of patients with early rheumatoid arthritis, enrolled 10 years apart.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  86. JOHNSON J, Yeter K, Rajbhandary R, Neal R, et al
    Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  87. CUOMO G, D'Abrsca V, Iacono D, Pantano I, et al
    The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  88. TANG MW, Koopman FA, Visscher JP, de Hair MJ, et al
    Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  89. YANG XK, Li P, Li S, Zhang C, et al
    Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  90. HIRAI T, Ikeda K, Fujishiro M, Tsushima H, et al
    The effectiveness of new triple combination therapy using synthetic disease-modifying anti-rheumatic drugs with different pharmacological function against rheumatoid arthritis: the verification by an in vitro and clinical study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  91. LOPPENTHIN K, Esbensen BA, Ostergaard M, Ibsen R, et al
    Welfare costs in patients with rheumatoid arthritis and their partners compared with matched controls: a register-based study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  92. NARAYAN N, Rigby S, Carlucci F
    Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  93. RIZZO R, Farina I, Bortolotti D, Galuppi E, et al
    The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  94. FLEISCHMANN R, Mease PJ, Schwartzman S, Hwang LJ, et al
    Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  95. ALFONSO-CRISTANCHO R, Armstrong N, Arjunji R, Riemsma R, et al
    Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  96. CHRISTOPOULOS G, Christopoulou V, Routsias JG, Babionitakis A, et al
    Greek rheumatoid arthritis patients have elevated levels of antibodies against antigens from Proteus mirabilis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  97. AN Y, Liu T, He D, Wu L, et al
    The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  98. DEODHAR A, Bitman B, Yang Y, Collier DH, et al
    The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  99. TAN YK, Allen JC Jr, Lye WK, Conaghan PG, et al
    Dichotomous versus semi-quantitative scoring of ultrasound joint inflammation in rheumatoid arthritis using novel individualized joint selection methods.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  100. EL-LEBEDY D, Hussein J, Ashmawy I, Mohammed AM, et al
    Serum level of neopterin is not a marker of disease activity in treated rheumatoid arthritis patients.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  101. TOZ B, Erer B
    Rheumatologic manifestations of primary immunodeficiency diseases: comment on the study by Dimitriades et al.
    Clin Rheumatol. 2016;35:2625.
    PubMed     Text format    


    September 2016
  102. PEHLIVAN S, Aydeniz A, Sever T, Altindag O, et al
    The functional variants of endothelial nitric oxide synthase gene associated with rheumatoid arthritis in Turkish adults.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  103. EL MIEDANY Y, El Gaafary M, Youssef S, Ahmed I, et al
    Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  104. MALAVIYA AN
    Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): effect of adding caffeine to the management regimen.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  105. HAJIALILO M, Ghorbanihaghjo A, Valaee L, Kolahi S, et al
    A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  106. KARATAS G, Bal A, Yuceege M, Yalcin E, et al
    The evaluation of sleep quality and response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis patients.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  107. HE J, Wang Y, Feng M, Zhang X, et al
    Dietary intake and risk of rheumatoid arthritis-a cross section multicenter study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  108. GIRAUD C, Tatar Z, Soubrier M
    Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  109. MARTIN ES, Schneeberger EE, Aranda FM, Peres SW, et al
    The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  110. LATAR I, Koufany M, Hablot J, Loeuille D, et al
    Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  111. SHOVMAN O, Tiosano S, Comaneshter D, Cohen AD, et al
    Aortic aneurysm associated with rheumatoid arthritis: a population-based cross-sectional study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  112. UPALA S, Yong WC, Sanguankeo A
    Association between primary Sjogren's syndrome and pregnancy complications: a systematic review and meta-analysis.
    Clin Rheumatol. 2016;35:1949-55.
    PubMed     Text format     Abstract available


  113. JUNG JY, Suh CH, Sohn S, Nam JY, et al
    Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
    Clin Rheumatol. 2016;35:1937-42.
    PubMed     Text format     Abstract available


  114. DALL'ARA F, Frassi M, Tincani A, Airo P, et al
    A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?
    Clin Rheumatol. 2016;35:2117-23.
    PubMed     Text format     Abstract available


  115. HIDER SL, Blagojevic-Bucknall M, Whittle R, Clarkson K, et al
    What does a primary care annual review for RA include? A national GP survey.
    Clin Rheumatol. 2016;35:2137-8.
    PubMed     Text format    


    July 2016
  116. MECOLI CA, Delev NG, Bingham CO 3rd
    Measuring transaminases in patients with rheumatoid arthritis on weekly methotrexate: does timing of blood testing matter?
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  117. CURTIS JR, Zhang R, Krishnaswami S, Anisfeld A, et al
    Use of a risk characterisation approach to contextualise the safety profile of new rheumatoid arthritis treatments: a case study using tofacitinib.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  118. ZAMORA-LEGOFF JA, Krause ML, Crowson CS, Ryu JH, et al
    Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  119. CEN H, Huang H, Zhang LN, Liu LY, et al
    Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  120. IANNONE F, Sinigaglia L, Favalli EG, Sarzi-Puttini P, et al
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  121. VENTURA-RIOS L, Hernandez-Diaz C, Sanchez-Bringas G, Madrigal-Santillan E, et al
    A descriptive, cross-sectional study characterizing bone erosions in rheumatoid arthritis and gout by ultrasound.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  122. SFRISO P, Priori R, Valesini G, Rossi S, et al
    Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.
    Clin Rheumatol. 2016;35:1683-9.
    PubMed     Text format     Abstract available


  123. NAKAJIMA A, Aoki Y, Sonobe M, Watanabe F, et al
    Relative expression and correlation of tumor necrosis factor-alpha, interferon-gamma, and interleukin-17 in the rheumatoid synovium.
    Clin Rheumatol. 2016;35:1691-7.
    PubMed     Text format     Abstract available


  124. LOYOLA-SANCHEZ A, Richardson J, Pelaez-Ballestas I, Alvarez-Nemegyei J, et al
    The impact of arthritis on the physical function of a rural Maya-Yucateco community and factors associated with its prevalence: a cross sectional, community-based study.
    Clin Rheumatol. 2016;35 Suppl 1:25-34.
    PubMed     Text format     Abstract available


    June 2016
  125. PIERINGER H, Danninger K, Puchner R, Hoppe UC, et al
    Urinary albumin excretion in patients with rheumatoid arthritis in a large cross-sectional study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  126. BHATI M, Bandyopadhyay S
    Efficacy and safety of an anti-CD20 monoclonal antibody (Reditux) for the treatment of patients with moderate to severe rheumatoid arthritis following the failure of conventional synthetic disease-modifying anti-rheumatic drugs.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  127. ZAMORA-LEGOFF JA, Myasoedova E, Matteson EL, Achenbach SJ, et al
    Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  128. CIURTIN C, Wyszynski K, Clarke R, Mouyis M, et al
    Ultrasound-detected subclinical inflammation was better reflected by the disease activity score (DAS-28) in patients with suspicion of inflammatory arthritis compared to established rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  129. EPIS O, Scioscia C, Locaputo A, Cappelli A, et al
    Use of ultrasound in treatment decisions for patients with rheumatoid arthritis: an observational study in Italy.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  130. YANG X, Xiao F, Luo D, Wang G, et al
    Interleukin 12B gene polymorphisms and susceptibility to rheumatoid arthritis: a data synthesis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  131. MADSEN OR
    Stability of clinical outcome measures in rheumatoid arthritis patients with stable disease defined on the basis of the EULAR response criteria.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  132. DAGAN A, Kogan M, Shoenfeld Y, Segal G, et al
    When uncommon and common coalesce: adult onset Still's disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA).
    Clin Rheumatol. 2016;35:1643-8.
    PubMed     Text format     Abstract available


    May 2016
  133. DURAN-AVELAR MJ, Vibanco-Perez N, Hernandez-Pacheco RR, Castro-Zambrano AD, et al
    STAT4 rs7574865 G/T polymorphism is associated with rheumatoid arthritis and disease activity, but not with anti-CCP antibody levels in a Mexican population.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  134. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  135. OSIRI M, Wongpiyabovorn J, Sattayasomboon Y, Thammacharoenrach N, et al
    Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  136. CHEN XX, Li ZG, Wu HX, Zhao DB, et al
    A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  137. ZHANG Y, Yang Y, Bai Y, Yang D, et al
    Clinical characteristics and follow-up analysis of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis.
    Clin Rheumatol. 2016;35:1145-51.
    PubMed     Text format     Abstract available


  138. UMEDA N, Matsumoto I, Kawaguchi H, Kurashima Y, et al
    Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
    Clin Rheumatol. 2016;35:1181-8.
    PubMed     Text format     Abstract available


  139. CHEN S, Deng C, Hu C, Li J, et al
    Association of MCP-1-2518A/G polymorphism with susceptibility to autoimmune diseases: a meta-analysis.
    Clin Rheumatol. 2016;35:1169-79.
    PubMed     Text format     Abstract available


  140. NEWSUM EC, van der Helm-van Mil AH, Kaptein AA
    Views on clinically suspect arthralgia: a focus group study.
    Clin Rheumatol. 2016;35:1347-52.
    PubMed     Text format     Abstract available


  141. NOTA I, Drossaert CH, Taal E, van de Laar MA, et al
    Arthritis patients' motives for (not) wanting to be involved in medical decision-making and the factors that hinder or promote patient involvement.
    Clin Rheumatol. 2016;35:1225-35.
    PubMed     Text format     Abstract available


  142. NAKAMURA T, Hirakawa K, Takaoka H, Iyama K, et al
    Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome.
    Clin Rheumatol. 2016;35:1403-9.
    PubMed     Text format     Abstract available


  143. SCRIVO R, Sauzullo I, Mengoni F, Riccieri V, et al
    The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature.
    Clin Rheumatol. 2016;35:1383-8.
    PubMed     Text format     Abstract available


  144. COZZI A, Papagrigoraki A, Biasi D, Colato C, et al
    Cutaneous manifestations of adult-onset Still's disease: a case report and review of literature.
    Clin Rheumatol. 2016;35:1377-82.
    PubMed     Text format     Abstract available


    April 2016
  145. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  146. YE H, Su Y, Li R, Zhao J, et al
    Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  147. MALAVIYA AN, Gogia SB
    Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  148. LOBO FS, Dossi MO, Batista L, Shinzato MM, et al
    Hearing impairment in patients with rheumatoid arthritis: association with anti-citrullinated protein antibodies.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  149. ESER B, Sahin N
    Evaluation of tool-like receptor-2 and 4 and interleukin-6 gene expressions in Turkish rheumatoid arthritis patients.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  150. GALVAO TF, Zimmermann IR, da Mota LM, Silva MT, et al
    Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  151. HAN GM, Han XF
    Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  152. LI L, Wen W, Jia R, Li Y, et al
    GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  153. GUTIERREZ M, Pineda C, Salaffi F, Raffeiner B, et al
    Is ankle involvement underestimated in rheumatoid arthritis? Results of a multicenter ultrasound study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  154. ACAR A, Guzel S, Sarifakioglu B, Guzel EC, et al
    Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  155. WANG F, Chen FF, Gao WB, Wang HY, et al
    Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using LC-MALDI-TOF/TOF.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  156. LANGE U, Dischereit G, Tarner I, Frommer K, et al
    The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  157. FATIMAH N, Salim B, Nasim A, Hussain K, et al
    Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  158. SFRISO P, Caso F, Filardo GS, Botsios C, et al
    Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  159. QUINTANA-DUQUE MA, Rondon-Herrera F, Mantilla RD, Calvo-Paramo E, et al
    Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  160. DIMITRIADES VR, Sorensen R
    Rheumatologic manifestations of primary immunodeficiency diseases.
    Clin Rheumatol. 2016;35:843-50.
    PubMed     Text format     Abstract available


  161. HERNANDEZ-DIAZ C, Ventura-Rios L, Gutierrez M, Roth J, et al
    Ultrasonography in pediatric rheumatology in Latin America. Expanding the frontiers.
    Clin Rheumatol. 2016;35:1077-80.
    PubMed     Text format     Abstract available


  162. YANG Y, Peng L, Ma W, Yi F, et al
    Autoantigen-targeting microRNAs in Sjogren's syndrome.
    Clin Rheumatol. 2016;35:911-7.
    PubMed     Text format     Abstract available


  163. MURALIDHARAN N, Mariaselvam CM, Mithun CB, Negi VS, et al
    Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
    Clin Rheumatol. 2016;35:879-85.
    PubMed     Text format     Abstract available


  164. MARIBO T, de Thurah A, Stengaard-Pedersen K
    Patient-self assessment of flare in rheumatoid arthritis: translation and reliability of the Flare instrument.
    Clin Rheumatol. 2016;35:1053-8.
    PubMed     Text format     Abstract available


  165. LEUNG YY, Kwan J, Chan P, Poon PK, et al
    A pilot evaluation of Arthritis Self-Management Program by lay leaders in patients with chronic inflammatory arthritis in Hong Kong.
    Clin Rheumatol. 2016;35:935-41.
    PubMed     Text format     Abstract available


    March 2016
  166. ZAMORA-LEGOFF JA, Achenbach SJ, Crowson CS, Krause ML, et al
    Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  167. AKIYAMA M, Kaneko Y, Kondo H, Takeuchi T, et al
    Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  168. RINCON JF, Cano DL, Morales SJ, Jimenez ML, et al
    The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  169. KIM SK, Choe JY, Park SH, Lee H, et al
    No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  170. CARDONA-OSPINA JA, Vera-Polania F, Rodriguez-Morales AJ
    Chikungunya or not, differential diagnosis and the importance of laboratory confirmation for clinical and epidemiological research: comment on the article by Rosario et al.
    Clin Rheumatol. 2016;35:829-30.
    PubMed     Text format    


  171. JAYAKANTHAN K, Ramya J, Mandal SK, Sandhya P, et al
    Younger patients with primary Sjogren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.
    Clin Rheumatol. 2016;35:657-62.
    PubMed     Text format     Abstract available


  172. TER BORG EJ, Kelder JC
    Polyarthritis in primary Sjogren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    Clin Rheumatol. 2016;35:649-55.
    PubMed     Text format     Abstract available


  173. AUGUSTO KL, Bonfa E, Pereira RM, Bueno C, et al
    Metabolic syndrome in Sjogren's syndrome patients: a relevant concern for clinical monitoring.
    Clin Rheumatol. 2016;35:639-47.
    PubMed     Text format     Abstract available


  174. RUBAN TN, Jacob B, Pope JE, Keystone EC, et al
    The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.
    Clin Rheumatol. 2016;35:759-63.
    PubMed     Text format     Abstract available


  175. JAUREGUI JJ, Kapadia BH, Dixit A, Naziri Q, et al
    Thirty-day complications in rheumatoid patients following total knee arthroplasty.
    Clin Rheumatol. 2016;35:595-600.
    PubMed     Text format     Abstract available


  176. GONZALEZ GARCIA A, Callejas Rubio JL, Rios Fernandez R, Ortego Centeno N, et al
    Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjogren syndrome.
    Clin Rheumatol. 2016;35:825-8.
    PubMed     Text format     Abstract available


  177. BISHARA R, Braun-Moscovici Y, Dagan A, Toledano K, et al
    Severe hyperferritinemia--a clue for severe hepatitis in a patient with adult-onset Still's disease.
    Clin Rheumatol. 2016;35:795-800.
    PubMed     Text format     Abstract available


  178. FINA-AVILES F, Medina-Peralta M, Mendez-Boo L, Hermosilla E, et al
    The descriptive epidemiology of rheumatoid arthritis in Catalonia: a retrospective study using routinely collected data.
    Clin Rheumatol. 2016;35:751-7.
    PubMed     Text format     Abstract available


    February 2016
  179. KRAUSE D, Gabriel B, Herborn G, Braun J, et al
    Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  180. FISHMAN P, Cohen S
    The A adenosine receptor (AAR): therapeutic target and predictive biological marker in rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  181. AKAI T, Taniguchi D, Oda R, Asada M, et al
    Prediction of radiographic progression in synovitis-positive joints on maximum intensity projection of magnetic resonance imaging in rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  182. STEUNEBRINK LM, Vonkeman HE, Ten Klooster PM, Hoekstra M, et al
    Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  183. KOJIMA T, Takahashi N, Funahashi K, Asai S, et al
    Improved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  184. VEGA-MORALES D, Loredo-Alanis SA, Garza-Elizondo MA
    Pain-related comorbidities and medication absence as predictors of clinical remission in RA.
    Clin Rheumatol. 2016;35:553-4.
    PubMed     Text format    


  185. PIERINGER H, Puchner R, Pohanka E, Danninger K, et al
    Power of national economy, disease control and employment status in patients with RA-an analytical multi-site ecological study.
    Clin Rheumatol. 2016;35:461-5.
    PubMed     Text format     Abstract available


  186. SASAKI T, Nakamura W, Inokuma S, Matsubara E, et al
    Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients.
    Clin Rheumatol. 2016;35:541-5.
    PubMed     Text format     Abstract available


  187. DE THURAH A, Maribo T, Stengaard-Pedersen K
    Patient self-assessment of flare in rheumatoid arthritis: criterion and concurrent validity of the Flare instrument.
    Clin Rheumatol. 2016;35:467-71.
    PubMed     Text format     Abstract available


  188. MACMULLAN PA, Madigan AM, Paul N, Peace AJ, et al
    Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis.
    Clin Rheumatol. 2016;35:447-55.
    PubMed     Text format     Abstract available


    January 2016
  189. PIANTONI S, Colombo E, Tincani A, Airo P, et al
    Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  190. GARDETTE A, Ottaviani S, Sellam J, Berenbaum F, et al
    Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  191. LENG X, Xiao W, Xu Z, Zhu X, et al
    Ultrasound7 versus ultrasound12 in monitoring the response to infliximab in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  192. LI R, Liu X, Ye H, Yao HH, et al
    Magnetic resonance imaging in early rheumatoid arthritis: a multicenter, prospective study.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  193. DE CUYPER E, De Gucht V, Maes S, Van Camp Y, et al
    Determinants of methotrexate adherence in rheumatoid arthritis patients.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  194. VASILJEVIC D, Veselinovic M, Jovanovic M, Jeremic N, et al
    Evaluation of the effects of different supplementation on oxidative status in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  195. HAH JH, An SY, Sim S, Kim SY, et al
    A population-based study on the association between rheumatoid arthritis and voice problems.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  196. ILTER A, Kiris A, Karkucak M, Sahin M, et al
    Arterial stiffness is associated with left ventricular dysfunction in patients with rheumatoid arthritis.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  197. BEN KILANI MS, Achour Y, Perea J, Cornelis F, et al
    Characterization of copy number variants for CCL3L1 gene in rheumatoid arthritis for French trio families and Tunisian cases and controls.
    Clin Rheumatol. 2016.
    PubMed     Text format     Abstract available


  198. KOJIMA T, Takahashi N, Kaneko A, Kida D, et al
    Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients.
    Clin Rheumatol. 2016;35:219-25.
    PubMed     Text format     Abstract available


  199. CHEN Y, Sun J, Yang Y, Huang Y, et al
    Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.
    Clin Rheumatol. 2016;35:1-18.
    PubMed     Text format     Abstract available


  200. GUO Q, Zha X, Li C, Jia Y, et al
    Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
    Clin Rheumatol. 2016;35:73-9.
    PubMed     Text format     Abstract available


  201. OLIVARES-MARTINEZ E, Hernandez-Ramirez DF, Nunez-Alvarez CA, Cabral AR, et al
    The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.
    Clin Rheumatol. 2016;35:55-61.
    PubMed     Text format     Abstract available


  202. BEN-ZVI I, Goldenberg I, Matetzky S, Grossman C, et al
    The impact of inflammatory rheumatic diseases on the presentation, severity, and outcome of acute coronary syndrome.
    Clin Rheumatol. 2016;35:233-7.
    PubMed     Text format     Abstract available


  203. SINGH JA, Ramachandran R
    Time trends in total ankle arthroplasty in the USA: a study of the National Inpatient Sample.
    Clin Rheumatol. 2016;35:239-45.
    PubMed     Text format     Abstract available


    December 2015
  204. COLMEGNA I, Hitchon CA, Bardales MC, Puri L, et al
    High rates of obesity and greater associated disability among people with rheumatoid arthritis in Canada.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


  205. BERGSTRA SA, Markusse IM, Akdemir G, Ronday HK, et al
    Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


  206. IGUCHI-HASHIMOTO M, Hashimoto M, Fujii T, Hamaguchi M, et al
    The association between serious infection and disease outcome in patients with rheumatoid arthritis.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


  207. EL-ZORKANY B, Mokbel A, Gamal SM, Mousa M, et al
    Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


  208. ACKERMAN IN, Ngian GS, Van Doornum S, Briggs AM, et al
    A systematic review of interventions to improve knowledge and self-management skills concerning contraception, pregnancy and breastfeeding in people with rheumatoid arthritis.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  209. YILDIRIM A, Surucu G, Dogan S, Karabiber M, et al
    Relationship between disease activity and hearing impairment in patients with rheumatoid arthritis compared with controls.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


  210. WANG P, Guan SY, Xu SZ, Li HM, et al
    Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


  211. MORPETH T, Brenton-Rule A, Carroll M, Frecklington M, et al
    Fear of falling and foot pain, impairment and disability in rheumatoid arthritis: a case-control study.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


  212. IANNONE F, Lopalco G, Cantarini L, Galeazzi M, et al
    Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritis.
    Clin Rheumatol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  213. LIU SS, Ding Y, Lou JQ
    IL-17, a potential therapeutic target for Sjogren's syndrome?
    Clin Rheumatol. 2015;34:1657-8.
    PubMed     Text format    


    May 2015
  214. LIU J, Zhao Z, Zou Y, Zhang M, et al
    The expression of death decoy receptor 3 was increased in the patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2015;34:879-85.
    PubMed     Text format     Abstract available


  215. CITERA G, Ficco HM, Alamino RS, Pra FD, et al
    Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina.
    Clin Rheumatol. 2015;34:929-33.
    PubMed     Text format     Abstract available


  216. GRANADOS Y, Cedeno L, Rosillo C, Berbin S, et al
    Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: a COPCORD study.
    Clin Rheumatol. 2015;34:871-7.
    PubMed     Text format     Abstract available


  217. KATADA H, Yukawa N, Urushihara H, Tanaka S, et al
    Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan.
    Clin Rheumatol. 2015;34:949-56.
    PubMed     Text format     Abstract available


    April 2015
  218. MOUYIS M, Fitz-Clarence H, Manson J, Ciurtin C, et al
    Teriparatide: an unexpected adjunct for the treatment of a long-standing infected elbow prosthesis prevented arm amputation.
    Clin Rheumatol. 2015;34:799-800.
    PubMed     Text format     Abstract available


  219. WITTE T
    Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?
    Clin Rheumatol. 2015;34:629-34.
    PubMed     Text format     Abstract available


  220. KREITENBERG AJ, Ortiz EC, Arkfeld DG
    Priapism after tumor necrosis factor alpha inhibitor use.
    Clin Rheumatol. 2015;34:801-2.
    PubMed     Text format     Abstract available


    March 2015
  221. LIANG MH, Couto MC, Duarte CC, Gall V, et al
    An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks.
    Clin Rheumatol. 2015;34:465-70.
    PubMed     Text format     Abstract available


  222. BAGNATO G, De Andres I, Sorbara S, Verduci E, et al
    Pain threshold and intensity in rheumatic patients: correlations with the Hamilton Depression Rating scale.
    Clin Rheumatol. 2015;34:555-61.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: